Company Website: http://zlk.9nl.com/orexigen-therapeutics-orex
NEW YORK -- (Business Wire)

Levi & Korsinsky, LLP is investigating Orexigen Therapeutics, Inc. (NasdaqGS: OREX), and its Board of Directors, in connection with possible claims of breaches of fiduciary duty.

To get more information, click here: http://zlk.9nl.com/orexigen-therapeutics-orex/. There is no cost or obligation to you.

If you own common stock in Orexigen Therapeutics, Inc. and wish to obtain additional information, please contact Eduard Korsinsky, Esq. either via email at ek@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/orexigen-therapeutics-orex/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, and Washington D.C. The firm has extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major securities lawsuits and have successfully recovered multimillion-dollar damages awards on behalf of investors. For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
www.zlk.com

Contacts:

Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
ek@zlk.com
(212) 363-7500, toll-free: (877) 363-5972

Source: Levi & Korsinsky, LLP